Pfizer

Pfizer

Pfizer is an American, multinational pharmaceutical and biotechnology corporation.

Pfizer is an American, multinational pharmaceutical and biotechnology corporation. The company was founded in 1849, in New York, New York, United States.

Pfizer has the mission to fund programs that provide public benefit, advance medical care, and can improve patient outcomes. Their researchers preform 25,000 clinical tests everyday for pharmaceutical development and innovations.

Partnerships
BaseLaunch

Pfizer is a partner with the BaseLaunch startup accelerator. The BaseLaunch program receives applications in the fields of therapeutics, diagnostics, digital healthcare, healthcare services, therapeutic platforms, and medical technology.

Insilico Medicine

Insilico Medicine and Pfizer entered into a research collaboration agreement. The agreement allows Pfizer to utilize Insilico Medicine's machine learning technology and Pandomics Discovery Platform to research potential therapeutic targets for a variety of diseases.

AMRA Medical

AMRA Medical and Pfizer's partnership works to investigate body fat distribution and muscle composition in a range of diseases using the UK Biobank registry. The partnership involves the body composition analysis of 100,000 individuals.

CytoReason

Pfizer's partnership with CytoReason gives them access to CytoReason's machine learning platform for drug discovery and development.

XtalPi Inc.

XtalPi Inc. and Pfizer's research collaboration focuses on developing a hybrid physics-and artificial intelligence-powered software platform for accurate molecular modeling of small molecules. The platform is intended to advance both companies capabilities in drug design and solid-form selection.

Distributed Bio

Pfizer and Distributed Bio entered an agreement to license Distributed Bio's SuperHuman Platform to Pfizer. The SuperHuman 2.0 antibody discovery platform will allow Pfizer to utilize the antibody library for screening activities against Pfizer-selected targets.

Domain Therapeutics

Domain Therapeutics and Pfizer entered into a collaboration agreement to asses Domain Therapeutics's bioSensAll platform. The bioSensAll platform defines signaling signatures for each wild-type and mutant receptors. Pfizer aims to use the platform to assess the impact of mutations on different signaling pathways engaged by g protein-coupled receptors.

COVID-19

Pfizer announced that they have identified certain antiviral compounds that are under development which could be effective in treating the novel coronavirus SARS-CoV-2 responsible for COVID-19. They may enter a partnership with a third party company to screen and identify potential compounds by the end of March, 2020 in order to begin testing in April, 2020.

Pfizer is partnered with BioNTech for co-development and distribution of an mRNA vaccine against SARS-CoV-2 called BNT162.

Timeline

January 11, 2021
Today in healthcare news: EQRx has raised another $500 million, at least 50% of COVID-19 cases spread from people without symptoms, and some evidence that Pfizer's vaccine works against virus mutations.
November 19, 2020
Pfizer and LianBio announce strategic collaboration to expand development of Novel Therapeutics in Greater China.
November 17, 2020
Pfizer launches Covid-19 vaccine delivery trial in four US states.
November 12, 2020
Commission approves contract with BioNTech-Pfizer alliance to ensure access to a potential vaccine

The European Commission approved a fourth contract with pharmaceutical companies BioNTech and Pfizer, which provides for the initial purchase of 200 million doses on behalf of all EU Member States, plus an option to request up to a further 100 million doses, to be supplied once a vaccine has proven to be safe and effective against COVID-19. Member States can decide to donate the vaccine to lower and middle-income countries or to re-direct it to other European countries.

November 9, 2020
Pfizer announces that the COVID-19 vaccine it's been developing is 90% effective in people who are not known to already have had the virus.
May 19, 2020
Pfizer and Adage bump up Amplyx's series C to top $90 million.

January 14, 2020
Insilico enters into research collaboration with Pfizer Inc. to explore novel data and artificial intelligence system for potential therapeutic targets.
2020
Pfizer and BioNTech enter a contract with the U.S. government to deliver 100 million doses of the vaccine worth $1.95 billion.
August 21, 2019
Pfizer announces an additional half billion dollar investment for the construction of its gene therapy manufacturing facility in Sanford, North Carolina.
June 17, 2019
Pfizer acquires Array BioPharma for $11.4 billion.
Page 1 of 2

Funded Companies

Company
Description
Industry
Website
Location
Molecular Stethoscope

A molecular diagnostics company developing novel blood-based early detection and disease monitoring tests based on analyzing circulating cell-free messenger RNA (cf-mRNA) in blood samples to monitor organ function.

Cortexyme is a biotechnology company with a focus on developing therapeutics for Alzheimer's disease and other neurodegenerative diseases. It was founded in 2012 and is located in San Francisco, California.

A genetic medicines company in Massachusetts that focuses on patients suffering from rare genetic diseases.

Trillium Therapeutics is a biotechnology company developing cancer immunotherapies.

Amplyx Pharmaceuticals, Inc. is a preclinical stage company focusing on the development of small molecule drugs.

SpringWorks Therapeutics is a Stamford, Connecticut-based company founded in 2017 by Lara S. Sullivan.

FoRx Therapeutics is a Basel-based biotechnology company developing a drug discovery platform for cancer drugs.

A company developing therapies for cancer and immune disorders

Arrakis Therapeutics is a Waltham, Massachusetts-based company.

Strata is a Lake Forest, California-based company founded in 1995.

AnTolRx is a Cambridge, Massachusetts-based company.

Aquinnah Pharmaceuticals is a Cambridge, Massachusetts-based company.

NextCure is a Beltsville, Maryland-based company.

16 Results
Results per page:
Page 1 of 1

Products

Product
Description
Launch date
Industry
Website
Ondansetron

Chemical compound

315 Results
Results per page:
Page 1 of 13
...

People

Name
Role
LinkedIn

A. Santiesteban

Employee

Abby Michaud

Employee

Abdalrahman Mekky, CMA

Employee

Abinaya A

Employee

Abiola Joseph

Employee

Abraham Svinkelstin, PMP, MS, MS, CSSGB

Employee

Adam Escalante

Employee

Adekunle Adeniran

Employee

Agnes Lei

Employee

AHMET ADIYAMAN

Employee

Aimee Greene

Employee

Aindréas MacDomhnaill

Employee

Aine Aherne

Employee

Akanqsha Shetty

Employee

Alba Hernandez

Employee

Alec Robert Gilarde

Employee

Alejandra Fonseca

Employee

Alekhya Reddy

Employee

Alex Haddad

Employee

Alexander H. Buell

Employee

Alexandra Grossbarth

Employee

Alexey Chapyshev

Employee

Alican Liceoglu

Employee

Alisha Dhiman

Employee

Alison Hanlon

Employee

Page 1 of 28
...

Further reading

Title
Author
Link
Type
Date

Breaking the Rules of Biology to Beat Rare Genetic Disease | Pfizer

Web

Our Science: Pharmaceutical Development | Pfizer | Pfizer

Web

Pfizer's Core Values of Social Responsibility and Philanthropy | Pfizer

Web

What to Know About Coronavirus -- COVID-19 Explained | Pfizer

Web

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Pfizer

Alberta Bourla

New York, New York, United States

Medical, healthcare, biotechnology, and pharmaceutical products and services

News

Title
Author
Date
Publisher
Description
Aria Bendix
February 25, 2021
Business Insider
The nation could now distribute 500 million doses by the end of June -- enough to vaccinate all of its adult population.
AP | PTI
February 25, 2021
@bsindia
Health authorities say first-generation Covid-19 vaccines still protect against variants that are emerging in different parts of the world
Dr. Catherine Schuster-Bruce
February 25, 2021
Business Insider
Pfizer's COVID-19 vaccine was 94% effective against symptomatic coronavirus, a week after the second dose. This compared to 95% in clinical trials.
BIS Research
February 25, 2021
www.prnewswire.com:443
/PRNewswire/ -- The premium market intelligence report published by BIS Research titled Global Cell and Gene Therapy Market highlights that the market is...
Andrea Michelson
February 25, 2021
Business Insider
Vaccine makers are testing the safety and efficacy of third doses now to prepare to address new coronavirus variants later.
Jordan Kelly-Linden
February 25, 2021
The Telegraph
The rollout of the Oxford/AstraZeneca vaccine has begun in the UK - here is everything we know so far
Telegraph reporters
February 25, 2021
The Telegraph
The Covid-19 vaccination programme is under way - the largest in British history
February 25, 2021
International Business Times UK
US biotech firm Moderna also announced its new Covid vaccine candidate aimed at the dangerous South African coronavirus variant had been shipped to government labs for testing.
Aylin Woodward
February 24, 2021
Business Insider
A preliminary study from Israel suggests people vaccinated against COVID-19 have lower viral loads, which are linked to less spread of the virus.
By LAURAN NEERGAARD and MATTHEW PERRONE, Associated Press
February 24, 2021
Chron
WASHINGTON (AP) -- Johnson & Johnson's single-dose vaccine offers strong...
Mitch Prothero
February 24, 2021
Business Insider
North Korea is well-practiced at drug smuggling and hacking, and needs as much foreign currency as it can get.
Jordan Kelly-Linden
February 24, 2021
The Telegraph
The rollout of the Oxford/AstraZeneca vaccine has begun in the UK - here is everything we know so far
Telegraph reporters
February 24, 2021
The Telegraph
The Covid-19 vaccination programme is under way - the largest in British history
Dr. Catherine Schuster-Bruce
February 23, 2021
Business Insider
The protection from Pfizer and BioNTech's COVID-19 vaccine increased to 85% after two shots in a study of more than 23,000 UK healthcare workers.
February 23, 2021
International Business Times UK
The Pfizer/BioNTech vaccine also has a 98 percent efficacy rate in preventing fever and breathing problems among patients.
Marianne Guenot
February 23, 2021
Business Insider
Officials in Europe report public resistance to the AstraZeneca vaccine. In the UK, some are avoiding the shot while others actively seek it.
Tim Stelloh
February 23, 2021
NBC News
Pfizer and Moderna said they're ramping up their supply of coronavirus vaccines, with shipments expected to double and possibly triple, according to congressional testimony.
Jordan Kelly-Linden
February 23, 2021
The Telegraph
The rollout of the Oxford/AstraZeneca vaccine has begun in the UK - here is everything we know so far
Telegraph reporters
February 23, 2021
The Telegraph
The Covid-19 vaccination programme is under way - the largest in British history
By DANICA KIRKA, Associated Press
February 22, 2021
Chron
LONDON (AP) -- Two U.K. studies released Monday showed that COVID-19 vaccination...
SHOW MORE

References

Page 1 of 3
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.